v3.26.1
Shareholders' Equity - Schedule of Share-Based Payment Arrangement Option (Details) - USD ($)
5 Months Ended 7 Months Ended 12 Months Ended
Dec. 31, 2024
Jul. 23, 2024
Dec. 31, 2023
Dec. 31, 2024
Jul. 23, 2024
Dec. 31, 2025
Predecessor [Member]            
Schedule of Share-Based Payment Arrangement Option [Line Items]            
Number of options, Outstanding   14,257 5,657   14,257  
Weighted average exercise price, Outstanding (in Dollars per share)   $ 100 $ 100   $ 100  
Weighted average remaining contractual terms (in years), Outstanding     9 years 10 months 17 days   9 years 7 months 9 days  
Aggregate intrinsic value, Outstanding (in Dollars)      
Number of options, Vested and expected   7,129     7,129  
Weighted average exercise price, Vested and expected (in Dollars per share)   $ 100     $ 100  
Weighted average remaining contractual terms (in years), Vested and expected         9 years 7 months 9 days  
Aggregate intrinsic value, Vested and expected (in Dollars)        
Number of options, Exercisable   7,129     7,129  
Weighted average exercise price, Exercisable (in Dollars per share)   $ 100     $ 100  
Weighted average remaining contractual terms (in years), Exercisable         9 years 7 months 9 days  
Aggregate intrinsic value, Exercisable (in Dollars)        
Number of options, Grants         8,600  
Weighted average exercise price, Grants (in Dollars per share)         $ 100  
Weighted average remaining contractual terms (in years), Grants         10 years  
Aggregate intrinsic value, Grants (in Dollars)          
Successor [Member]            
Schedule of Share-Based Payment Arrangement Option [Line Items]            
Number of options, Outstanding 4,960,000 7,020,000   4,960,000 7,020,000 4,270,000
Weighted average exercise price, Outstanding (in Dollars per share) $ 0.3 $ 0.18   $ 0.3 $ 0.18 $ 0.3
Weighted average remaining contractual terms (in years), Outstanding 6 years 1 month 6 days 6 years 1 month 6 days   6 years 1 month 6 days   4 years 10 months 24 days
Aggregate intrinsic value, Outstanding (in Dollars)  
Number of options, Forfeited           (690,000)
Weighted average exercise price, Forfeited (in Dollars per share)          
Number of options, Vested and expected 4,960,000     4,960,000   4,270,000
Weighted average exercise price, Vested and expected (in Dollars per share) $ 0.3     $ 0.3   $ 0.3
Weighted average remaining contractual terms (in years), Vested and expected       6 years 1 month 6 days   4 years 10 months 24 days
Aggregate intrinsic value, Vested and expected (in Dollars)      
Number of options, Exercisable 3,790,000     3,790,000   4,270,000
Weighted average exercise price, Exercisable (in Dollars per share) $ 0.38     $ 0.38   $ 0.38
Weighted average remaining contractual terms (in years), Exercisable       5 years 1 month 6 days   5 years 1 month 6 days
Aggregate intrinsic value, Exercisable (in Dollars)      
Number of options, Grants       740,000    
Weighted average exercise price, Grants (in Dollars per share)       $ 0.3    
Weighted average remaining contractual terms (in years), Grants       10 years    
Aggregate intrinsic value, Grants (in Dollars)          
Number of options, Exercised       (2,800,000)